China Medical University, China
Clinical trials sponsored by China Medical University, China, explained in plain language.
-
New drug cocktail aims to keep aggressive lung cancer at bay
Disease control Not yet recruitingThis study is testing a combination of four drugs to see if they can help control extensive-stage small cell lung cancer after initial chemotherapy. The treatment involves intravenous infusions and daily pills, and patients continue taking some drugs long-term to try to delay the…
Phase: PHASE2 • Sponsor: China Medical University, China • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
New hope for tough lung cancer: testing combo therapy when first treatments fail
Disease control Not yet recruitingThis study is testing a new two-drug combination for people with extensive-stage small cell lung cancer whose cancer has gotten worse after their first treatment. The treatment combines an intravenous drug that targets cancer cells with a daily pill that aims to cut off the tumor…
Phase: PHASE2 • Sponsor: China Medical University, China • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Virus-Based therapy targets Tough-to-Treat liver tumors
Disease control Not yet recruitingThis early-stage study is testing a new three-part treatment for people whose colorectal cancer has spread to the liver and other treatments have stopped working. The treatment combines a specially engineered virus designed to attack cancer cells with an immunotherapy drug and a …
Phase: PHASE1 • Sponsor: China Medical University, China • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC